193 related articles for article (PubMed ID: 36057396)
1. Surface analysis of sequential semi-solvent vapor impact (SAVI) for studying microstructural arrangements of poly(lactide-co-glycolide) microparticles.
Garner J; Skidmore S; Hadar J; Park H; Park K; Qin B; Wang Y
J Control Release; 2022 Oct; 350():600-612. PubMed ID: 36057396
[TBL] [Abstract][Full Text] [Related]
2. Scanning Analysis of Sequential Semisolvent Vapor Impact To Study Naltrexone Release from Poly(lactide-co-glycolide) Microparticles.
Garner J; Skidmore S; Hadar J; Park H; Park K; Otte A; Jhon YK; Xu X; Qin B; Wang Y
Mol Pharm; 2022 Nov; 19(11):4286-4298. PubMed ID: 36166409
[TBL] [Abstract][Full Text] [Related]
3. Complex sameness: Separation of mixed poly(lactide-co-glycolide)s based on the lactide:glycolide ratio.
Skidmore S; Hadar J; Garner J; Park H; Park K; Wang Y; Jiang XJ
J Control Release; 2019 Apr; 300():174-184. PubMed ID: 30853529
[TBL] [Abstract][Full Text] [Related]
4. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
5. Analysis of semi-solvent effects for PLGA polymers.
Garner J; Skidmore S; Hadar J; Park H; Park K; Kuk Jhon Y; Qin B; Wang Y
Int J Pharm; 2021 Jun; 602():120627. PubMed ID: 33915188
[TBL] [Abstract][Full Text] [Related]
6. Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type.
Soppimath KS; Aminabhavi TM
J Microencapsul; 2002; 19(3):281-92. PubMed ID: 12022494
[TBL] [Abstract][Full Text] [Related]
7. Microparticles produced by the hydrogel template method for sustained drug delivery.
Lu Y; Sturek M; Park K
Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release.
Birnbaum DT; Kosmala JD; Henthorn DB; Brannon-Peppas L
J Control Release; 2000 Apr; 65(3):375-87. PubMed ID: 10699296
[TBL] [Abstract][Full Text] [Related]
9. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
10. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
11. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
Intra J; Salem AK
J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
[TBL] [Abstract][Full Text] [Related]
12. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
Luan X; Bodmeier R
J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
[TBL] [Abstract][Full Text] [Related]
13. One-step surface modification of poly(lactide-co-glycolide) microparticles with heparin.
Cui C; Schwendeman SP
Pharm Res; 2007 Dec; 24(12):2381-93. PubMed ID: 17710516
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
15. Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded plga microparticles via spray-drying.
Wan F; Bohr A; Maltesen MJ; Bjerregaard S; Foged C; Rantanen J; Yang M
Pharm Res; 2013 Apr; 30(4):1065-76. PubMed ID: 23263784
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
Haddadi A; Farboud ES; Erfan M; Aboofazeli R
J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
[TBL] [Abstract][Full Text] [Related]
17. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives.
Chung TW; Tsai YL; Hsieh JH; Tsai WJ
J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974
[TBL] [Abstract][Full Text] [Related]
18. Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates.
Garcia JT; Fariña JB; Munguía O; Llabrés M
J Microencapsul; 1999; 16(1):83-94. PubMed ID: 9972505
[TBL] [Abstract][Full Text] [Related]
19. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
[TBL] [Abstract][Full Text] [Related]
20. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
Liang D; Frank S; Schwendeman SP
Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
